Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Meta-analysis of exome array data identifies six novel genetic loci for lung function.

Jackson VE, Latourelle JC, Wain LV, Smith AV, Grove ML, Bartz TM, Obeidat M, Province MA, Gao W, Qaiser B, Porteous DJ, Cassano PA, Ahluwalia TS, Grarup N, Li J, Altmaier E, Marten J, Harris SE, Manichaikul A, Pottinger TD, Li-Gao R, Lind-Thomsen A, Mahajan A, Lahousse L, Imboden M, Teumer A, Prins B, Lyytikäinen LP, Eiriksdottir G, Franceschini N, Sitlani CM, Brody JA, Bossé Y, Timens W, Kraja A, Loukola A, Tang W, Liu Y, Bork-Jensen J, Justesen JM, Linneberg A, Lange LA, Rawal R, Karrasch S, Huffman JE, Smith BH, Davies G, Burkart KM, Mychaleckyj JC, Bonten TN, Enroth S, Lind L, Brusselle GG, Kumar A, Stubbe B; Understanding Society Scientific Group, Kähönen M, Wyss AB, Psaty BM, Heckbert SR, Hao K, Rantanen T, Kritchevsky SB, Lohman K, Skaaby T, Pisinger C, Hansen T, Schulz H, Polasek O, Campbell A, Starr JM, Rich SS, Mook-Kanamori DO, Johansson Å, Ingelsson E, Uitterlinden AG, Weiss S, Raitakari OT, Gudnason V, North KE, Gharib SA, Sin DD, Taylor KD, O'Connor GT, Kaprio J, Harris TB, Pederson O, Vestergaard H, Wilson JG, Strauch K, Hayward C, Kerr S, Deary IJ, Barr RG, de Mutsert R, Gyllensten U, Morris AP, Ikram MA, Probst-Hensch N, Gläser S, Zeggini E, Lehtimäki T, Strachan DP, Dupuis J, Morrison AC, Hall IP, Tobin MD, London SJ.

Wellcome Open Res. 2018 Jan 12;3:4. doi: 10.12688/wellcomeopenres.12583.3. eCollection 2018.

2.

Tau induces blood vessel abnormalities and angiogenesis-related gene expression in P301L transgenic mice and human Alzheimer's disease.

Bennett RE, Robbins AB, Hu M, Cao X, Betensky RA, Clark T, Das S, Hyman BT.

Proc Natl Acad Sci U S A. 2018 Feb 6;115(6):E1289-E1298. doi: 10.1073/pnas.1710329115. Epub 2018 Jan 22.

3.

Meta-analysis of the association between urokinase-plasminogen activator gene rs2227564 polymorphism and Alzheimer's disease.

Wu W, Jiang H, Wang M, Zhang D.

Am J Alzheimers Dis Other Demen. 2013 Aug;28(5):517-23. doi: 10.1177/1533317513494450. Epub 2013 Jun 28.

PMID:
23813610
4.

The role of ECE1 variants in cognitive ability in old age and Alzheimer's disease risk.

Hamilton G, Harris SE, Davies G, Liewald DC, Tenesa A, Payton A, Horan MA, Ollier WE, Pendleton N; Genetic and Environmental Risk for Alzheimer's Disease (GERAD1) Consortium, Starr JM, Porteous D, Deary IJ.

Am J Med Genet B Neuropsychiatr Genet. 2012 Sep;159B(6):696-709. doi: 10.1002/ajmg.b.32073. Epub 2012 Jun 12.

PMID:
22693153
5.

No replication of genetic association between candidate polymorphisms and Alzheimer's disease.

Cousin E, Macé S, Rocher C, Dib C, Muzard G, Hannequin D, Pradier L, Deleuze JF, Génin E, Brice A, Campion D.

Neurobiol Aging. 2011 Aug;32(8):1443-51. doi: 10.1016/j.neurobiolaging.2009.09.004. Epub 2009 Nov 3.

PMID:
19889475
6.

Confronting complexity in late-onset Alzheimer disease: application of two-stage analysis approach addressing heterogeneity and epistasis.

Thornton-Wells TA, Moore JH, Martin ER, Pericak-Vance MA, Haines JL.

Genet Epidemiol. 2008 Apr;32(3):187-203.

7.

Effect of heterogeneity on the chromosome 10 risk in late-onset Alzheimer disease.

Liang X, Martin ER, Schnetz-Boutaud N, Bartlett J, Anderson B, Züchner S, Gwirtsman H, Schmechel D, Carney R, Gilbert JR, Pericak-Vance MA, Haines JL.

Hum Mutat. 2007 Nov;28(11):1065-73.

PMID:
17573676
8.

The urokinase-type plasminogen activator polymorphism PLAU_1 is a risk factor for APOE-epsilon4 non-carriers in the Italian Alzheimer's disease population and does not affect the plasma Abeta(1-42) level.

Pesaresi M, Batelli S, Prato F, Polito L, Lovati C, Scarpini E, Quadri P, Mariani C, Albani D, Forloni G.

Neurobiol Dis. 2007 Mar;25(3):609-13. Epub 2006 Dec 15.

PMID:
17174555
9.

Association of tagSNPs in the urokinase-plasminogen activator (PLAU) gene with Alzheimer's disease and associated quantitative traits.

Ozturk A, Minster RL, DeKosky ST, Kamboh MI.

Am J Med Genet B Neuropsychiatr Genet. 2007 Jan 5;144B(1):79-82.

PMID:
16967469
10.

A functional polymorphism within plasminogen activator urokinase (PLAU) is associated with Alzheimer's disease.

Riemenschneider M, Konta L, Friedrich P, Schwarz S, Taddei K, Neff F, Padovani A, Kölsch H, Laws SM, Klopp N, Bickeböller H, Wagenpfeil S, Mueller JC, Rosenberger A, Diehl-Schmid J, Archetti S, Lautenschlager N, Borroni B, Müller U, Illig T, Heun R, Egensperger R, Schlegel J, Förstl H, Martins RN, Kurz A.

Hum Mol Genet. 2006 Aug 15;15(16):2446-56. Epub 2006 Jul 6.

PMID:
16825285
11.

Towards compendia of negative genetic association studies: an example for Alzheimer disease.

Blomqvist ME, Reynolds C, Katzov H, Feuk L, Andreasen N, Bogdanovic N, Blennow K, Brookes AJ, Prince JA.

Hum Genet. 2006 Mar;119(1-2):29-37. Epub 2005 Dec 8.

PMID:
16341549
12.

The urokinase-plasminogen activator (PLAU) gene is not associated with late onset Alzheimer's disease.

Bagnoli S, Tedde A, Cellini E, Rotondi M, Nacmias B, Sorbi S.

Neurogenetics. 2005 Feb;6(1):53-4. Epub 2004 Dec 23. No abstract available. Erratum in: Neurogenetics. 2005 May;6(2):105.

PMID:
15616835
13.

Elevated amyloid beta protein (Abeta42) and late onset Alzheimer's disease are associated with single nucleotide polymorphisms in the urokinase-type plasminogen activator gene.

Ertekin-Taner N, Ronald J, Feuk L, Prince J, Tucker M, Younkin L, Hella M, Jain S, Hackett A, Scanlin L, Kelly J, Kihiko-Ehman M, Neltner M, Hersh L, Kindy M, Markesbery W, Hutton M, de Andrade M, Petersen RC, Graff-Radford N, Estus S, Brookes AJ, Younkin SG.

Hum Mol Genet. 2005 Feb 1;14(3):447-60. Epub 2004 Dec 22.

PMID:
15615772
14.

No association of a non-synonymous PLAU polymorphism with Alzheimer's disease and disease-related traits.

Papassotiropoulos A, Tsolaki M, Wollmer MA, Molyva D, Thal DR, Huynh KD, Tracy J, Staehelin HB, Monsch AU, Nitsch RM, Hock C.

Am J Med Genet B Neuropsychiatr Genet. 2005 Jan 5;132B(1):21-3.

PMID:
15558716
15.

Genetic variants in a haplotype block spanning IDE are significantly associated with plasma Abeta42 levels and risk for Alzheimer disease.

Ertekin-Taner N, Allen M, Fadale D, Scanlin L, Younkin L, Petersen RC, Graff-Radford N, Younkin SG.

Hum Mutat. 2004 Apr;23(4):334-42.

PMID:
15024728
16.

Variation in the urokinase-plasminogen activator gene does not explain the chromosome 10 linkage signal for late onset AD.

Myers AJ, Marshall H, Holmans P, Compton D, Crook RJ, Mander AP, Nowotny P, Smemo S, Dunstan M, Jehu L, Wang JC, Hamshere M, Morris JC, Norton J, Chakraventy S, Tunstall N, Lovestone S, Petersen R, O'Donovan M, Jones L, Williams J, Owen MJ, Hardy J, Goate A.

Am J Med Genet B Neuropsychiatr Genet. 2004 Jan 1;124B(1):29-37.

PMID:
14681909
17.

Association of late-onset Alzheimer disease with a genotype of PLAU, the gene encoding urokinase-type plasminogen activator on chromosome 10q22.2.

Finckh U, van Hadeln K, Müller-Thomsen T, Alberici A, Binetti G, Hock C, Nitsch RM, Stoppe G, Reiss J, Gal A.

Neurogenetics. 2003 Aug;4(4):213-7. Epub 2003 Jul 24.

PMID:
12898287

Supplemental Content

Loading ...
Support Center